Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 (Xiaflex) for Peyronie's Disease
NCT01221623Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Oct 2010
- Primary completion
- Mar 2012
- Modality
- Therapeutic Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Started Oct 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT01221623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01221623.